A carregar...

Progress in Immunotherapy for Non-small Cell Lung Cancer

In recent years, the five-year survival rate of patients with advanced stage non-small cell lung cancer (NSCLC) remains low despite recent advances in surgery, irradiation, chemotherapy, and targeted therapy. Immunotherapy which utilizes the immune system to control and eradicate cancer is a viable...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yan XU, Mengzhao WANG
Formato: Artigo
Idioma:Chinês
Publicado em: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2014-01-01
Colecção:Chinese Journal of Lung Cancer
Assuntos:
Acesso em linha:http://dx.doi.org/10.3779/j.issn.1009-3419.2014.01.06
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!